Smell-RS
Smell-RS is developing a digital diagnostic device for testing olfactory function, which is an early symptom of neurodegenerative diseases that affect 10% of the population. Smell-RS Team: Andreas Keller,…
Read MoreUnicrobe
We will provide bacterial genome editing services using CRISPR-Cas technologies for academic and industrial customers interested in improving human health and developing bacterial technologies. Team: Wenyan Jiang – CEO, CSO…
Read MoreAmyloCap
W Vallen Graham has harnessed a novel method to capture native protofibrillar amyloid structures to make a library of conformation-specific monoclonal antibodies that detect early amyloid disease. AmyloCap Team: W.…
Read MoreTirgan BioPharmaceuticals
Focusing on developing new drugs for treatment of Keloid Disorder: 1) reformulating a generic drug into a sustained release product using nano-technology; 2) purifying plant extract to create a new…
Read MoreBrainSeq
BrainSeq is the first biotechnology company to use the brain’s nanoscale architecture to innovate the diagnosis and treatment of brain diseases. BrainSeq Team: Eliot Dow
Read MoreBioharmony Therapy
Bioharmony Therapeutics is an early-stage biotech startup focused on the development of first-in-class antimicrobials that target infections caused by Gram-negative bacteria. Bioharmony Theraputics Team: Chandrabali Ghose-Paul, Founder and CEO
Read MoreLysimmune BioScience
Platform technology to produce recombinant therapeutic antibodies against Staphylococcus aureus and other pathogens, targeting cell wall carbohydrates not adequately recognized by the human immune system. Team: Assaf Raz, PhD…
Read More